Analyst Ratings for Inhibrx Biosciences (INBX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2024 | Citizens » Updated 12/17/2025 |
Reni Benjamin | New Coverage | Market Perform (N/A) |
N/A (N/A) |
12.88 (69.18) |
437.11% | Details |
| 3/16/2022 | SMBC Nikko Securities | David Dai | New Coverage | Outperform (N/A) |
40.00 (N/A) |
20.19 (69.18) |
242.64% | Details |
![]() |
||||||||
![]() |
||||||||


